DOD Biotech (Thailand) Today
| DOD Stock | 2.56 0.16 5.88% |
Performance0 of 100
| Odds Of DistressLess than 10
|
DOD Biotech is selling for 2.56 as of the 19th of April 2024. This is a -5.88 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 2.54. DOD Biotech has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for DOD Biotech Public are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Moving together with DOD Stock
| 0.68 | TFMAMA | Thai President Foods | PairCorr |
| 0.91 | TVO | Thai Vegetable Oil | PairCorr |
| 0.77 | RBF | RB Food Supply | PairCorr |
Moving against DOD Stock
| 0.8 | GFPT | GFPT Public | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DOD Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DOD Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DOD Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Packaged Foods, Consumer Defensive, Computing (View all Sectors) |
DOD Biotech Public (DOD) is traded on Thailand Exchange in Thailand and employs 6 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DOD Biotech's market, we take the total number of its shares issued and multiply it by DOD Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DOD Biotech Public operates under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 410 M outstanding shares.
DOD Biotech generates positive cash flow from operations, but has no cash available
Check DOD Biotech Probability Of Bankruptcy
Ownership AllocationDOD Biotech Public retains a total of 410 Million outstanding shares. DOD Biotech Public retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check DOD Ownership Details
DOD Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of DOD Biotech jumping above the current price in 90 days from now is close to 99%. The DOD Biotech Public probability density function shows the probability of DOD Biotech stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon DOD Biotech has a beta of 0.1831 suggesting as returns on the market go up, DOD Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding DOD Biotech Public will be expected to be much smaller as well. Additionally, dOD Biotech Public has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of DOD Biotech to move above the current price in 90 days from now is close to 99 (This DOD Biotech Public probability density function shows the probability of DOD Stock to fall within a particular range of prices over 90 days) .
DOD Biotech Public Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. DOD Biotech market risk premium is the additional return an investor will receive from holding DOD Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DOD Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although DOD Biotech's alpha and beta are two of the key measurements used to evaluate DOD Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.03 | |||
| Standard Deviation | 1.62 | |||
| Variance | 2.62 | |||
| Risk Adjusted Performance | (0.20) |
DOD Stock Against Markets
Picking the right benchmark for DOD Biotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in DOD Biotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for DOD Biotech is critical whether you are bullish or bearish towards DOD Biotech Public at a given time. Please also check how DOD Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in DOD Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
DOD Biotech Corporate Management
Elected by the shareholders, the DOD Biotech's board of directors comprises two types of representatives: DOD Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DOD. The board's role is to monitor DOD Biotech's management team and ensure that shareholders' interests are well served. DOD Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DOD Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dusit Chongsutthanamanee | Independent Sec | Profile | |
| Thanin Srisethi | Director CEO | Profile | |
| Suwarin Konthong | Chief CFO | Profile | |
| Nattawat Phetthai | Accounting Accountant | Profile | |
| Torlarp Chaiyachow | Acting Chairman | Profile | |
| Aekphusit Boonsiriyotthakul | COO Director | Profile |
How to buy DOD Stock?
Before investing in DOD Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in DOD Biotech. To buy DOD Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of DOD Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase DOD Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located DOD Biotech Public stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased DOD Biotech Public stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as DOD Biotech Public, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in DOD Biotech Public?
The danger of trading DOD Biotech Public is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of DOD Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than DOD Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile DOD Biotech Public is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DOD Biotech Public. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the DOD Biotech Public information on this page should be used as a complementary analysis to other DOD Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for DOD Stock analysis
When running DOD Biotech's price analysis, check to measure DOD Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DOD Biotech is operating at the current time. Most of DOD Biotech's value examination focuses on studying past and present price action to predict the probability of DOD Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DOD Biotech's price. Additionally, you may evaluate how the addition of DOD Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |